Therapeutic Targeting of Intestinal Fibrosis in Crohn’s Disease

Giovanni Santacroce(Università Cattolica del Sacro Cuore), Antonio Di Sabatino(University of Pavia), Marco Vincenzo Lenti(University of Pavia)

Cells

January 26, 2022

10.3390/cells11030429

Cited by 71

Related Papers

Decline with age of the respiratory chain activity in human skeletal muscle

|Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease|1994|340

Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): Rationale and feasibility of a shared pragmatic protocol

|Nutrition|2020|264

Anemia in patients with Covid-19: pathogenesis and clinical significance

|Clinical and Experimental Medicine|2021|154

Role of mucosal immunity and epithelial–vascular barrier in modulating gut homeostasis

|Internal and Emergency Medicine|2023|98

Opening the doors of precision medicine: novel tools to assess intestinal barrier in inflammatory bowel disease and colitis-associated neoplasia

|Gut|2024|96